Norwegian biotech company Hofseth BioCare (HBC) has announced the resignation of Chief Financial Officer (CFO) Christel Elise Kanli.
Kanli is stepping down to pursue opportunities outside the company.
“I would like to thank Christel for her efforts and positive contributions to HBC. I wish her all the best of luck in her future endeavors,” said Jon Olav Ødegård, CEO of HBC.
HBC has begun the process of identifying a successor for the CFO role.
In July 2023, Roger Hofseth stepped down from his position as CEO of HBC, handing control of the company over to Jon Olav Odegard, who had been company’s chief financial officer.